Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Regional Cervical Cord Atrophy and Disability in Multiple Sclerosis: A Voxel-based Analysis.
Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial.
Minocin
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis.
Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.
New Disease-Modifying Therapies and New Challenges for MS.
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.
Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis.
Quantitative proton density mapping: correcting the receiver sensitivity bias via pseudo proton densities.
Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
The value of the multiple sclerosis specialist nurse with respect to prevention of unnecessary emergency admission.
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Ligation of the jugular veins does not result in brain inflammation or demyelination in mice.
Effects of functional electrical stimulation on gait function and quality of life for people with multiple sclerosis taking dalfampridine.
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.
Safety and Tolerability of Glatiramer Acetate (GLACIER)
Anti-integrin therapy for multiple sclerosis.
AMP-Activated Protein Kinase Restricts IFN-γ Signaling.
Accentia Biopharmaceuticals Announces that Revimmune Autoimmune Disease Therapy is Featured in Peer-review Journal
Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi Patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
[Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids].
Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes.
Pages
« first
‹ previous
…
174
175
176
177
178
179
180
181
182
…
next ›
last »